ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/22/2024
Back to search
Official data from USPTO
EVALUATEPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVALUATEPHARMA
ST13
US500000085280941Class
9, 35, 42, 44
Filing
85280941
Registration
4095650
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
07/22/2024
Trademark type
Word
Nice classes
9, 35, 42, 44
Filing date
03/30/2011
Registration date
02/07/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2018
Last transaction
02/20/2024
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
01/15/1999
First use in commerce
01/15/1999
Drawing code
4
Owner type
03
Owner location
LONDON, GB
Examiner
BEN, LINDSEY HEATHER
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
PHARMA INTELLIGENCE U.K. LIMITED
EVALUATE GROUP LIMITED
Evaluate Limited
Representatives
Mark B. Mizrahi Saul Ewing, LLP
Technical classification
Nice Classes
Class 9Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computer software for use in database management in the pharmaceutical field; Downloadable software for use in database management in the pharmaceutical field
Class 35
Providing an on-line database providing business intelligence in the field of pharmaceuticals
Class 42
* non-downloadable computer software for use in database management in the pharmaceutical field; * Providing medical and scientific information in the field of pharmaceuticals
Class 44
Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; providing an on-line computer database in the field of pharmaceutical advice
Publications
History of USPTO decisions and trademark events.
48 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/20/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2024
NCP7
NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED
08/09/2022
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
08/08/2022
C7P.
CANCELLED SEC. 7 - PARTIAL
08/08/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/18/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
02/07/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/07/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/27/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/27/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/07/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/07/2019
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/25/2018
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/25/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/01/2018
ES8R
TEAS SECTION 8 RECEIVED
02/07/2018
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/13/2017
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/13/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2011
PUBO
PUBLISHED FOR OPPOSITION
11/22/2011
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/17/2011
ALIE
ASSIGNED TO LIE
10/17/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2011
GNRT
NON-FINAL ACTION E-MAILED
07/11/2011
CNRT
NON-FINAL ACTION WRITTEN
07/11/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/29/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2011
GNRT
NON-FINAL ACTION E-MAILED
06/27/2011
CNRT
NON-FINAL ACTION WRITTEN
06/27/2011
DOCK
ASSIGNED TO EXAMINER
06/27/2011
MPMK
NOTICE OF PSEUDO MARK MAILED
04/05/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2011
NWAP
NEW APPLICATION ENTERED
04/03/2011
Continuous trademark protection
Get notified about every new filing that threatens EVALUATEPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.